Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 12151-12200 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04513223
A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors
PHASE1
Active, not recruiting
101 participants
Started: Mar 30, 2021 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT04871282
A Study of AL102 in Patients With Progressing Desmoid Tumors
PHASE2/PHASE3
Active, not recruiting
198 participants
Started: Mar 30, 2021 · Completed: Oct 31, 2026
2 conditions
1 sponsor
53 locations
NCT05013333
AED 3 Post-Approval Study
NA
Active, not recruiting
38 participants
Started: Mar 30, 2021 · Completed: Feb 28, 2029
1 condition
1 sponsor
2 locations
NCT04703686
Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy
PHASE2
Active, not recruiting
67 participants
Started: Mar 30, 2021 · Completed: Mar 1, 2026
5 conditions
1 sponsor
15 locations
NCT04484142
Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)
PHASE2
Active, not recruiting
137 participants
Started: Mar 30, 2021 · Completed: Dec 12, 2025
1 condition
2 sponsors
84 locations
NCT04600362
Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema
PHASE2
Active, not recruiting
70 participants
Started: Mar 30, 2021 · Completed: Jan 31, 2027
1 condition
2 sponsors
1 location
NCT04673617
AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
PHASE1/PHASE2
Active, not recruiting
45 participants
Started: Mar 29, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
21 locations
NCT04704986
Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF
PHASE4
Active, not recruiting
201 participants
Started: Mar 29, 2021 · Completed: Jul 31, 2025
1 condition
2 sponsors
2 locations
NCT05434312
TGRX-678 Chinese Phase I in Chronic Myelogenous Leukemia (CML) Patients
PHASE1
Active, not recruiting
90 participants
Started: Mar 29, 2021 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT04785287
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
PHASE1/PHASE2
Active, not recruiting
13 participants
Started: Mar 29, 2021 · Completed: May 27, 2027
17 conditions
1 sponsor
1 location
NCT04523922
Oxytocin to Enhance Integrated Treatment for AUD and PTSD
PHASE2
Active, not recruiting
180 participants
Started: Mar 29, 2021 · Completed: Jan 1, 2026
2 conditions
2 sponsors
1 location
NCT04824443
Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19
PHASE1
Active, not recruiting
3 participants
Started: Mar 29, 2021 · Completed: Mar 29, 2026
3 conditions
1 sponsor
7 locations
NCT04695925
Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 Mutations
PHASE3
Active, not recruiting
294 participants
Started: Mar 29, 2021 · Completed: Dec 30, 2027
2 conditions
4 sponsors
2 locations
NCT05273957
A Model of Hospital-Territory Management Coordinated by a Case Manager to Improve the Care of Patients With Parkinsonism.
NA
Active, not recruiting
121 participants
Started: Mar 29, 2021 · Completed: Jun 30, 2025
5 conditions
2 sponsors
2 locations
NCT04530942
The Efficacy and Prediction of Deep Brain Stimulation for Treatment-resistant Depression
NA
Active, not recruiting
34 participants
Started: Mar 29, 2021 · Completed: Dec 30, 2024
2 conditions
1 sponsor
1 location
NCT04460040
Exercise-Induced Metabolic Compensation; a Physiological Adaptive Response to Exercise Training
NA
Active, not recruiting
16 participants
Started: Mar 27, 2021 · Completed: Nov 1, 2024
1 condition
2 sponsors
1 location
NCT04634058
PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment
PHASE2
Active, not recruiting
40 participants
Started: Mar 26, 2021 · Completed: Sep 30, 2025
3 conditions
1 sponsor
1 location
NCT04551040
Target Engagement of Terazosin in Healthy Adults
PHASE1
Active, not recruiting
18 participants
Started: Mar 26, 2021 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT04954001
Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1
PHASE1/PHASE2
Active, not recruiting
160 participants
Started: Mar 26, 2021 · Completed: Mar 30, 2025
3 conditions
1 sponsor
14 locations
NCT04303104
Xpert Active Case-finding Trial 3 (XACT-3)
NA
Active, not recruiting
3,394 participants
Started: Mar 26, 2021 · Completed: Dec 30, 2025
1 condition
7 sponsors
4 locations
NCT04713345
VERARE_2 Efficacy of the Observation of Virtual Motor Actions for the Improvement of Gait in Patients With ICU-weakness
NA
Active, not recruiting
68 participants
Started: Mar 26, 2021 · Completed: Sep 2, 2025
1 condition
2 sponsors
1 location
NCT05157802
Promoting Physical Activity Engagement for People With Early-stage Cerebellar Ataxia
PHASE1
Active, not recruiting
30 participants
Started: Mar 26, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04639414
Combined Active Treatment in Type 2 Diabetes with NASH
PHASE4
Active, not recruiting
192 participants
Started: Mar 26, 2021 · Completed: Dec 31, 2025
3 conditions
6 sponsors
26 locations
NCT04783415
Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma
PHASE2
Active, not recruiting
12 participants
Started: Mar 26, 2021 · Completed: Sep 20, 2025
1 condition
2 sponsors
1 location
NCT04404153
Neurostimulation for Cognitive Enhancement in Alzheimer's Disease
NA
Active, not recruiting
100 participants
Started: Mar 25, 2021 · Completed: Jan 31, 2026
2 conditions
3 sponsors
1 location
NCT04744428
Trial of Autism Parent Navigator Program
NA
Active, not recruiting
360 participants
Started: Mar 25, 2021 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT04790474
Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib
PHASE2
Active, not recruiting
61 participants
Started: Mar 25, 2021 · Completed: Sep 1, 2029
2 conditions
1 sponsor
7 locations
NCT04566666
To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
PHASE2
Active, not recruiting
263 participants
Started: Mar 25, 2021 · Completed: Apr 30, 2025
1 condition
1 sponsor
50 locations
NCT04845503
Stereotactic MRI-guided Radiation Therapy for Localized prostatE Cancer
NA
Active, not recruiting
68 participants
Started: Mar 25, 2021 · Completed: Mar 25, 2028
1 condition
3 sponsors
1 location
NCT04728451
Spectacle Prescribing in Early Childhood
NA
Active, not recruiting
88 participants
Started: Mar 25, 2021 · Completed: Feb 28, 2027
2 conditions
2 sponsors
1 location
NCT04199871
Improving Control of Alignment in Intermittent Exotropia
NA
Active, not recruiting
84 participants
Started: Mar 25, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04521153
Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma
PHASE2/PHASE3
Active, not recruiting
294 participants
Started: Mar 25, 2021 · Completed: Mar 1, 2026
3 conditions
1 sponsor
1 location
NCT04646902
Kynurenine/Tryptophan Ratio in Hypertension Associated to Obstructive Sleep Apnea
N/A
Active, not recruiting
203 participants
Started: Mar 25, 2021 · Completed: Mar 1, 2024
1 condition
6 sponsors
5 locations
NCT04805970
REsearching Covid-19 Outcomes in Diabetes (RECODE)
N/A
Active, not recruiting
35 participants
Started: Mar 24, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04931823
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
PHASE1
Active, not recruiting
126 participants
Started: Mar 24, 2021 · Completed: Mar 1, 2025
1 condition
2 sponsors
8 locations
NCT04586023
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
PHASE3
Active, not recruiting
751 participants
Started: Mar 24, 2021 · Completed: Jul 9, 2027
1 condition
1 sponsor
108 locations
NCT04806906
Pilot Study of CC 486 (Oral Azacitidine) Plus BSC as Maintenance After sc Azacitidine in Elderly HR-IPSS-R MDS Patients
PHASE2
Active, not recruiting
11 participants
Started: Mar 24, 2021 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT04745299
Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients with ALS
PHASE3
Active, not recruiting
115 participants
Started: Mar 23, 2021 · Completed: May 3, 2026
1 condition
1 sponsor
5 locations
NCT04727216
Intermittent vs. Continuous Dorsal Root Ganglion Stimulation
NA
Active, not recruiting
15 participants
Started: Mar 23, 2021 · Completed: Sep 15, 2021
2 conditions
1 sponsor
1 location
NCT04908410
The Norwegian Addiction, Pain and Trauma Study
N/A
Active, not recruiting
1,650 participants
Started: Mar 23, 2021 · Completed: Dec 31, 2030
3 conditions
5 sponsors
4 locations
NCT04443829
Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma
PHASE1
Active, not recruiting
12 participants
Started: Mar 23, 2021 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT04816825
Home-monitored Telerehabilitation in COPD Patients
NA
Active, not recruiting
92 participants
Started: Mar 23, 2021 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT04827563
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
N/A
Active, not recruiting
50 participants
Started: Mar 22, 2021 · Completed: Aug 1, 2026
4 conditions
1 sponsor
1 location
NCT04880174
SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination
NA
Active, not recruiting
500 participants
Started: Mar 22, 2021 · Completed: Jul 31, 2028
1 condition
1 sponsor
1 location
NCT04749862
Cancer Surveillance and Support
N/A
Active, not recruiting
565 participants
Started: Mar 22, 2021 · Completed: Jul 31, 2025
2 conditions
1 sponsor
1 location
NCT04098666
Metformin in Alzheimer's Dementia Prevention
PHASE2/PHASE3
Active, not recruiting
326 participants
Started: Mar 22, 2021 · Completed: Apr 30, 2027
1 condition
27 sponsors
22 locations
NCT04632810
Effect of Ketosis on Pain and Quality of Life in Patients With Lipedema
NA
Active, not recruiting
70 participants
Started: Mar 22, 2021 · Completed: Apr 30, 2025
1 condition
4 sponsors
2 locations
NCT04688255
Mobile Subthreshold Exercise Program for Concussion--R01
NA
Active, not recruiting
200 participants
Started: Mar 22, 2021 · Completed: Oct 31, 2025
6 conditions
2 sponsors
1 location
NCT04459507
A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan
N/A
Active, not recruiting
276 participants
Started: Mar 22, 2021 · Completed: Dec 29, 2025
1 condition
1 sponsor
39 locations
NCT04817007
A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)
PHASE1/PHASE2
Active, not recruiting
216 participants
Started: Mar 22, 2021 · Completed: May 31, 2026
1 condition
1 sponsor
53 locations
Previous
1
More pages
241
242
243
244
245
246
247
More pages
431
Next